PEX27 Antibody

What is PEX27 and what cellular functions does it perform?

PEX27 (encoded by YOR193w in yeast) is a peroxisomal protein that belongs to a family including PEX11p and PEX25p. It functions in peroxisome biogenesis and plays a significant role in peroxisome proliferation. PEX27 is highly similar to PEX25 in sequence, and both proteins are targeted to peroxisomes via the transport route for peroxisomal membrane proteins . Under normal conditions, PEX27 is constitutively expressed at low levels, unlike the more abundant and oleic acid-inducible proteins PEX11p and PEX25p. Functionally, PEX27 can rescue growth defects in pex25Δ mutant strains when overexpressed, indicating shared functionality with PEX25 .

How is PEX27 localized within cells and what techniques can confirm this localization?

PEX27 localizes to peroxisomes, as demonstrated through fluorescence microscopy using PEX27-GFP fusion proteins. When co-expressed with peroxisomal markers like PTS2-DsRed, PEX27 shows a punctate staining pattern that colocalizes with peroxisomal structures . For researchers looking to confirm PEX27 localization, fluorescence microscopy with GFP-tagged constructs remains the primary methodology. Additional confirmation can be obtained through subcellular fractionation followed by western blotting using specific anti-PEX27 antibodies. In mutant strains like pex13Δ, PEX27-GFP maintains its punctate pattern, while in pex19Δ strains (where membrane protein insertion is compromised), the staining appears diffuse, further confirming its nature as a peroxisomal membrane protein .

What is the relationship between PEX27, PEX25, and PEX11p in peroxisome function?

PEX27, PEX25, and PEX11p constitute a family of proteins with conserved functions in peroxisome biogenesis. While PEX11p is more abundant and strongly induced by oleic acid, PEX25 shows intermediate expression levels (also oleic acid-inducible), and PEX27 is expressed at constitutively low levels regardless of carbon source . Functionally, overexpression of any one of these proteins can partially compensate for the absence of the others. For example, overexpression of PEX27 in a pex11Δ pex25Δ pex27Δ triple mutant partially restores peroxisome function, though with morphological differences compared to wild type. The most effective rescue is achieved with PEX25 overexpression, which can almost completely restore peroxisomal matrix protein import in the triple mutant .

What are the recommended protocols for using PEX27 antibodies in immunofluorescence microscopy?

For immunofluorescence microscopy using PEX27 antibodies, researchers should follow these methodological steps:

• Fix cells using 4% paraformaldehyde for 15 minutes at room temperature

• Permeabilize with 0.1% Triton X-100 for 10 minutes

• Block with 3% BSA in PBS for 1 hour

• Incubate with primary PEX27 antibody (typically diluted 1:100-1:500 depending on antibody specificity) overnight at 4°C

• Wash three times with PBS

• Incubate with fluorescently-labeled secondary antibody for 1 hour at room temperature

• Counterstain with DAPI for nuclear visualization

• Mount and image using confocal microscopy

For validation, co-staining with established peroxisomal markers like PEX14 or catalase is recommended. When examining PEX27 localization in mutant backgrounds, proper controls should include wild-type cells and known peroxisomal marker proteins to distinguish between normal and aberrant localization patterns .

How can researchers effectively use PEX27 antibodies in Western blotting applications?

For optimal Western blotting results with PEX27 antibodies, researchers should:

• Prepare cell lysates using a membrane protein-compatible lysis buffer containing 1% Triton X-100 or similar detergent

• Separate proteins on 10-12% SDS-PAGE gels

• Transfer to PVDF membrane (preferable for membrane proteins)

• Block with 5% non-fat milk in TBST for 1 hour

• Incubate with primary PEX27 antibody (typically 1:1000 dilution) overnight at 4°C

• Wash extensively with TBST (3-5 times, 5 minutes each)

• Incubate with HRP-conjugated secondary antibody (1:5000) for 1 hour

• Develop using enhanced chemiluminescence

When interpreting results, researchers should note that epitope-tagged versions of PEX27, such as PEX27-TAP, have been successfully used for detection . The expected molecular weight for PEX27 should be verified based on the specific organism being studied. For quantitative comparisons, researchers should normalize to appropriate loading controls and consider the relatively low expression level of PEX27 compared to PEX11p and PEX25p .

How can researchers distinguish between direct and indirect effects of PEX27 on peroxisome proliferation?

Distinguishing direct from indirect effects of PEX27 on peroxisome proliferation requires multiple complementary approaches:

• Genetic dissection: Create single, double, and triple knockout combinations of PEX11, PEX25, and PEX27 to assess the specific contribution of each protein. The observation that pex11Δ pex25Δ pex27Δ triple mutants have severe peroxisome defects that can be rescued by overexpression of individual family members suggests partially overlapping functions .

• Protein-protein interaction studies: Employ co-immunoprecipitation, proximity labeling (BioID), or yeast two-hybrid assays to identify direct interaction partners of PEX27, which helps establish its position in peroxisomal protein networks.

• Temporal analysis: Use inducible expression systems to monitor the sequence of events following PEX27 induction. Time-course experiments capturing peroxisome morphology changes can help establish cause-effect relationships.

• Structure-function analysis: Generate PEX27 mutants with specific domain alterations to identify regions essential for peroxisome proliferation versus other functions.

• In vitro reconstitution: Purify PEX27 and assess its direct effects on membrane curvature or lipid dynamics using artificial membrane systems.

Research indicates that when overexpressed, PEX27 increases peroxisome numbers but results in organelles larger than wild-type, suggesting a distinct mechanism from PEX25, which can induce numerous small peroxisomes and even membrane proliferation resembling karmellae .

What are the technical challenges in generating and validating specific antibodies against PEX27?

Generating specific antibodies against PEX27 presents several technical challenges:

• Low endogenous expression levels: As PEX27 is constitutively expressed at low levels , detecting the endogenous protein requires highly sensitive antibodies. This necessitates careful immunization strategies and extensive validation.

• Sequence homology with PEX25: Due to the high sequence similarity between PEX27 and PEX25 , antibodies must be raised against unique epitopes to prevent cross-reactivity. Epitope mapping and selection are critical steps in antibody development.

• Membrane protein nature: As a peroxisomal membrane protein, PEX27 contains hydrophobic domains that may be poorly immunogenic or inaccessible in its native conformation.

• Validation requirements: Rigorous validation using multiple techniques is essential:

  • Western blotting of wild-type versus pex27Δ samples

  • Immunoprecipitation followed by mass spectrometry

  • Immunofluorescence comparing wild-type, overexpression, and knockout conditions

  • Testing for cross-reactivity with related proteins, especially PEX25

• Recombinant antigen production: For antibody generation, researchers typically use fusion proteins containing specific domains of PEX27 produced recombinantly in E. coli, similar to the approach used for PEX7 antibodies .

Each new antibody lot should undergo quality control testing on cells overexpressing the target protein to confirm the expected staining pattern .

What controls are essential when using PEX27 antibodies in various experimental setups?

When designing experiments with PEX27 antibodies, the following controls are essential:

• Genetic controls:

  • Wild-type cells/tissues (positive control)

  • pex27Δ mutant (negative control)

  • PEX27 overexpression (positive control with enhanced signal)

  • pex19Δ mutant (for membrane protein targeting studies)

• Technical controls for Western blotting:

  • Loading controls (housekeeping proteins)

  • Molecular weight markers

  • Purified recombinant PEX27 protein (if available)

  • Non-specific IgG (negative control)

  • Depletion control (pre-incubation of antibody with antigen)

• Controls for immunofluorescence:

  • Secondary antibody only

  • Co-staining with established peroxisomal markers (PEX14, catalase)

  • Non-peroxisomal organelle markers (mitochondria, ER, etc.)

  • Cells expressing fluorescently-tagged PEX27

• Controls for functionality studies:

  • Comparison with PEX11p and PEX25p mutants and overexpression

  • Peroxisome function assays (e.g., catalase activity measurements)

These controls help distinguish specific antibody binding from background and validate the observed PEX27 localization and function patterns.

How should researchers design experiments to study PEX27 interactions with other peroxisomal proteins?

To effectively study PEX27 interactions with other peroxisomal proteins, researchers should implement a multi-faceted experimental design:

• Co-immunoprecipitation (Co-IP):

  • Use PEX27 antibodies or epitope-tagged PEX27 (e.g., PEX27-TAP) to pull down protein complexes

  • Perform reciprocal Co-IPs with antibodies against suspected interaction partners

  • Include appropriate controls: IgG control, lysate from pex27Δ cells

• Proximity-based labeling:

  • Generate BioID or APEX2 fusions with PEX27

  • Identify proximal proteins through streptavidin pulldown and mass spectrometry

  • Compare results with similar experiments using PEX11p and PEX25p fusions

• Split-reporter assays:

  • Bimolecular Fluorescence Complementation (BiFC)

  • Split-luciferase assays

  • These can confirm interactions in living cells

• Yeast two-hybrid screening:

  • Use PEX27 as bait to screen for interacting partners

  • Validate positive hits with other methods

• In vitro binding assays:

  • GST pulldown or ELISA using purified components

  • Surface Plasmon Resonance (SPR) for binding kinetics

• Comparative analysis:

  • Study interactions in different conditions (e.g., oleic acid induction)

  • Compare interaction patterns between PEX27, PEX25, and PEX11p

What are common pitfalls in PEX27 antibody-based experiments and how can they be addressed?

Researchers working with PEX27 antibodies may encounter several challenges:

• Low signal intensity: Due to low endogenous expression levels of PEX27

  • Solution: Use signal amplification methods (TSA), longer exposure times, or sensitive detection systems

  • Alternative: Consider epitope-tagged versions for enhanced detection

• Cross-reactivity with PEX25: Given sequence similarity

  • Solution: Test antibody specificity using pex25Δ and pex27Δ controls

  • Alternative: Use epitope-tagged versions with tag-specific antibodies

• Inconsistent peroxisome morphology: PEX27 affects peroxisome size and number

  • Solution: Standardize growth conditions and carefully document peroxisome parameters

  • Alternative: Use automated image analysis to quantify morphological changes

• Variable expression levels: PEX27 expression is low compared to other family members

  • Solution: Normalize data to appropriate housekeeping genes/proteins

  • Alternative: Use genomic tagging to maintain endogenous expression levels

• Membrane protein solubilization issues:

  • Solution: Optimize lysis buffers with appropriate detergents (1% Triton X-100, 0.5% SDS)

  • Alternative: Consider membrane fractionation techniques

• Functional redundancy: Overlapping functions with PEX25 and PEX11p

  • Solution: Use multiple mutant backgrounds to isolate PEX27-specific effects

  • Alternative: Employ acute depletion methods (e.g., auxin-inducible degron)

For all these challenges, comprehensive documentation of experimental conditions and clear reporting of statistical methods are essential for reproducible results.

How can researchers accurately quantify PEX27 levels and localization in different experimental conditions?

Accurate quantification of PEX27 levels and localization requires rigorous methodological approaches:

• Protein level quantification:

  • Western blotting with recombinant protein standards for absolute quantification

  • Ratio to housekeeping proteins for relative quantification

  • Use of genomically-tagged PEX27 (e.g., PEX27-TAP) for consistent detection

  • Consider mass spectrometry-based approaches for absolute quantification

• mRNA level quantification:

  • RT-qPCR with validated reference genes

  • RNA-seq with appropriate normalization

  • Compare with expression patterns of PEX11 and PEX25

• Localization analysis:

  • Automated image analysis of fluorescence microscopy data

  • Colocalization coefficients (Pearson's, Mander's) with peroxisomal markers

  • Quantification of punctate vs. diffuse distribution

  • 3D reconstruction for volume and intensity measurements

• Experimental conditions to compare:

  • Different carbon sources (glucose vs. ethanol vs. oleic acid)

  • Growth phases

  • Stress conditions

  • Genetic backgrounds (wild-type vs. various pex mutants)

For example, research has shown that unlike PEX11p and PEX25p, PEX27 levels remain low regardless of carbon source, suggesting constitutive rather than inducible expression . Proper statistical analysis should include multiple biological replicates and appropriate statistical tests based on data distribution.

How should researchers interpret contradictory findings regarding PEX27 function across different model systems?

When confronted with contradictory findings regarding PEX27 function:

• Consider model system differences:

  • Yeast PEX27 has been primarily studied in Saccharomyces cerevisiae

  • Verify whether orthologs exist in other model systems

  • Compare sequence conservation and domain organization across species

• Examine experimental conditions:

  • Growth conditions significantly affect peroxisome biology (e.g., oleic acid induction)

  • Compare cell/tissue types used in different studies

  • Assess nutritional or stress conditions that might influence results

• Evaluate genetic backgrounds:

  • Different strain backgrounds may contain modifiers

  • Presence/absence of other peroxins can mask or enhance phenotypes

  • Consider the method of gene deletion/disruption

• Analyze methodology differences:

  • Overexpression vs. endogenous levels

  • Acute vs. chronic depletion

  • Different tagging strategies or antibodies

  • Various assays for peroxisome function

• Reconciliation strategies:

  • Perform side-by-side comparisons under identical conditions

  • Conduct epistasis experiments with other peroxins

  • Use complementary approaches to test the same hypothesis

For example, studies have shown that PEX27 overexpression can partially rescue peroxisome defects in triple mutants, but the resulting organelles differ morphologically from those rescued by PEX25 or PEX11p overexpression , suggesting both overlapping and distinct functions.

What statistical approaches are most appropriate for analyzing PEX27 antibody-generated data?

For rigorous analysis of PEX27 antibody-generated data, researchers should employ these statistical approaches:

• Western blot quantification:

  • Normalization to loading controls

  • Multiple biological replicates (minimum n=3)

  • Non-parametric tests for small sample sizes

  • ANOVA with post-hoc tests for multiple comparisons

• Immunofluorescence analysis:

  • Quantification of signal intensity (integrated density)

  • Morphometric analysis (size, number, distribution of puncta)

  • Colocalization coefficients with confidence intervals

  • Mixed-effects models for experiments with multiple cells per condition

• Functional assays:

  • Appropriate positive and negative controls

  • Regression analysis for dose-response relationships

  • Statistical power calculations based on expected effect sizes

  • Blinded analysis to prevent bias

• Recommended statistical tests:

  • t-test (paired or unpaired) for two-group comparisons

  • ANOVA with appropriate post-hoc tests for multiple groups

  • Non-parametric alternatives (Mann-Whitney, Kruskal-Wallis) for non-normal data

  • Multiple testing correction (Bonferroni, FDR) when appropriate

Data visualization should include clear representation of individual data points, error bars indicating standard deviation or standard error, and transparent reporting of sample sizes and outlier handling procedures.

What are the most promising future research directions for PEX27 antibody applications?

Future research using PEX27 antibodies should focus on several promising directions:

• Comparative proteomics: Using PEX27 antibodies for immunoprecipitation followed by mass spectrometry to identify interaction partners under different conditions, comparing with PEX11p and PEX25p interactomes.

• Structural biology: Generating structure-specific antibodies that recognize distinct conformational states of PEX27, potentially revealing dynamic changes during peroxisome proliferation.

• Developmental biology: Investigating PEX27 expression and localization during organism development and differentiation, particularly in specialized cells with prominent peroxisome functions.

• Human disease models: Exploring potential roles of PEX27 in peroxisomal disorders and testing whether it might serve as a compensatory target in diseases involving other peroxins.

• High-throughput screening: Developing PEX27 antibody-based assays for screens identifying compounds that modulate peroxisome proliferation.

• Super-resolution microscopy: Employing PEX27 antibodies in emerging super-resolution techniques to visualize peroxisome membrane dynamics at nanoscale resolution.

• In vivo studies: Developing tools for tracking PEX27 in living cells and organisms to monitor real-time changes in peroxisome dynamics.

Research has already established that PEX27 contributes to peroxisome biogenesis and proliferation , but further work is needed to elucidate its precise molecular mechanism and potential applications in treating peroxisomal disorders.

How can researchers integrate PEX27 antibody data with other -omics approaches for comprehensive peroxisome research?

Integrating PEX27 antibody data with multi-omics approaches enables comprehensive peroxisome research:

• Integration with genomics:

  • Correlate PEX27 localization/function with genetic variants

  • Analyze effects of PEX27 polymorphisms on peroxisome biology

  • Study epigenetic regulation of PEX27 expression

• Integration with transcriptomics:

  • Compare PEX27 protein levels with mRNA expression

  • Identify co-regulated genes across different conditions

  • Analyze splicing variants and their functional consequences

• Integration with proteomics:

  • Combine antibody-based studies with mass spectrometry

  • Map post-translational modifications of PEX27

  • Study PEX27 in the context of the peroxisomal proteome

• Integration with metabolomics:

  • Correlate PEX27 function with peroxisomal metabolite profiles

  • Assess impact of PEX27 manipulation on cellular metabolism

  • Identify metabolic signatures of peroxisome dysfunction

• Integration with structural biology:

  • Use antibodies to stabilize protein conformations for structural studies

  • Develop structure-specific antibodies based on predicted models

  • Validate structural predictions with antibody epitope mapping

• Computational integration:

  • Network analysis incorporating PEX27 interaction data

  • Machine learning approaches to predict PEX27 function

  • Systems biology modeling of peroxisome dynamics